Alliance Pharma, the Chippenham-based speciality pharmaceutical firm, is to receive £6.7m in compensation for lost sales of a bladder cancer treatment. ImmuCyst, one of its top-selling drugs, had peak annual sales of more than £4m before Alliance’s manufacturing partner French healthcare giant Sanofi Pasteur suspended production in mid-2012 at a Canadian plant after mold...